Strides gets U.S. nod for Gabapentin

Published - October 20, 2018 09:42 pm IST - Mumbai

Strides Pharma Science (Strides) announced that its global arm Strides Pharma Global Pte Singapore has received USFDA approval for Gabapentin capsules.

Gabapentin capsules is a generic version of Neurontin capsules of Pfizer Inc., said a release. The anti-convulsant or anti-epileptic drug is used with other medication to prevent and control seizures and is also used to relieve nerve pain following shingles in adults.

Strides Pharma Global Pte Singapore received approval for Gabapentin Capsules USP, 100 mg, 300 mg and 400 mg from the United States Food and Drug Administration. The product will be marketed by Strides Pharma Inc. in the U.S. market.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.